002737 logo

Sunflower Pharmaceutical Group Co., Ltd. Stock Price

SZSE:002737 Community·CN¥7.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002737 Share Price Performance

CN¥13.03
-2.90 (-18.20%)
CN¥13.03
-2.90 (-18.20%)
Price CN¥13.03

002737 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet second-rate dividend payer.

2 Risks
0 Rewards

Sunflower Pharmaceutical Group Co., Ltd. Key Details

CN¥2.5b

Revenue

CN¥1.4b

Cost of Revenue

CN¥1.1b

Gross Profit

CN¥1.3b

Other Expenses

-CN¥204.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 29, 2026
-0.35
43.00%
-8.19%
2.6%
View Full Analysis

About 002737

Founded
2005
Employees
5025
CEO
Yi Guan
WebsiteView website
www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines in China and internationally. It offers traditional Chinese medicines, chemical drugs, biological drugs, and health and wellness products, as well as adult and children’s medicines for various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold ailments, rheumatism and bone disease, cardiovascular and cerebrovascular diseases, and general health. The company is also involved in leasing and business services; scientific research and technical services; and wholesale and retail trade. It sells its products under the Sunflower and Little Sunflower brand names. The company was founded in 2005 and is headquartered in Harbin, China.

Recent 002737 News & Updates

Recent updates

No updates